These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22424892)

  • 21. Susceptibility locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit schizophrenia identified by latent class analysis.
    Holliday EG; McLean DE; Nyholt DR; Mowry BJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1058-67. PubMed ID: 19805696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four symptom dimensions in outpatients with schizophrenia.
    Villalta-Gil V; Vilaplana M; Ochoa S; Dolz M; Usall J; Haro JM; Almenara J; González JL; Lagares C;
    Compr Psychiatry; 2006; 47(5):384-8. PubMed ID: 16905401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of negative symptoms and associated factors in older adults with schizophrenia spectrum disorder.
    Cohen CI; Natarajan N; Araujo M; Solanki D
    Am J Geriatr Psychiatry; 2013 Feb; 21(2):100-7. PubMed ID: 23343483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimensional psychopathology of schizophrenia: SVARAD dimensional profiles in an acute inpatient sample.
    Valentini M; Biondi M; Pasquini M; Picardi A
    Riv Psichiatr; 2018; 53(1):40-48. PubMed ID: 29493653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimensions and subtypes of recent-onset schizophrenia. A longitudinal analysis.
    Willem Van der Does AJ; Dingemans PM; Linszen DH; Nugter MA; Scholte WF
    J Nerv Ment Dis; 1995 Nov; 183(11):681-7. PubMed ID: 7595429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latent structures underlying schizophrenic symptoms: a five-dimensional model.
    Nakaya M; Suwa H; Ohmori K
    Schizophr Res; 1999 Aug; 39(1):39-50. PubMed ID: 10480666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A latent structure analysis of the positive and negative symptoms in schizophrenia.
    Brekke JS; DeBonis JA; Graham JW
    Compr Psychiatry; 1994; 35(4):252-9. PubMed ID: 7956180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.
    Arndt S; Andreasen NC; Flaum M; Miller D; Nopoulos P
    Arch Gen Psychiatry; 1995 May; 52(5):352-60. PubMed ID: 7726715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of symptom dimensions in schizophrenia obtained with the Spanish version of the Manchester scale.
    Tabarés R; Sanjuán J; Gómez-Beneyto M; Leal C
    Psychopathology; 2000; 33(5):259-64. PubMed ID: 10965283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond symptom dimensions: schizophrenia risk factors for patient groups derived by latent class analysis.
    Leask SJ; Vermunt JK; Done DJ; Crow TJ; Blows M; Boks MP
    Schizophr Res; 2009 Dec; 115(2-3):346-50. PubMed ID: 19840897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment.
    Peralta V; Cuesta MJ
    Schizophr Res; 2001 Apr; 49(3):269-85. PubMed ID: 11356588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure of negative symptoms within schizophrenia: implications for assessment.
    Blanchard JJ; Cohen AS
    Schizophr Bull; 2006 Apr; 32(2):238-45. PubMed ID: 16254064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schizophrenic psychoses with affect-dominant symptoms : Contribution to a system-specific approach].
    Lang FU; Stegmayer K; Becker T; Jäger M
    Nervenarzt; 2016 Jul; 87(7):770-9. PubMed ID: 26646613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions.
    van der Gaag M; Cuijpers A; Hoffman T; Remijsen M; Hijman R; de Haan L; van Meijel B; van Harten PN; Valmaggia L; de Hert M; Wiersma D
    Schizophr Res; 2006 Jul; 85(1-3):273-9. PubMed ID: 16730430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of personality with intrinsic motivation in schizophrenia.
    Vohs JL; Lysaker PH; Nabors L
    Psychiatry Res; 2013 Jun; 208(1):78-80. PubMed ID: 23566367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor structure of the Bern Psychopathology Scale in a sample of patients with schizophrenia spectrum disorders.
    Lang FU; Stierlin AS; Stegmayer K; Walther S; Becker T; Jäger M
    Eur Psychiatry; 2015 Oct; 30(7):880-4. PubMed ID: 26443057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Standards for Negative Symptom Assessment.
    Carpenter WT; Blanchard JJ; Kirkpatrick B
    Schizophr Bull; 2016 Jan; 42(1):1-3. PubMed ID: 26615186
    [No Abstract]   [Full Text] [Related]  

  • 40. The psychopathological factors of refractory schizophrenia.
    Alves TM; Pereira JC; Elkis H
    Braz J Psychiatry; 2005 Jun; 27(2):108-12. PubMed ID: 15962134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.